Southlake, Texas, Dec. 01, 2022 (GLOBE NEWSWIRE) — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on saving lives by making an ECG (also known as an EKG) a far more valuable screening tool through the use of Artificial Intelligence (AI), today […]
Other News
Cardior Welcomes Dr. Orly Vardeny as Permanent Guest to the Board
HANOVER, Germany–(BUSINESS WIRE)–Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA (ncRNA)-based therapeutics for patients with cardiac diseases, today announced that Orly Vardeny, PharmD, MS, joins its Board of Directors as a permanent guest. Dr. Vardeny is an Associate professor of Medicine at the University of Minnesota Medical School, with […]
ISHLT Elects New Board Members and Professional Community Leaders
CHICAGO, Dec. 1, 2022 /PRNewswire/ — The International Society for Heart and Lung Transplantation (ISHLT) has announced the results of the 2022 member election for the 2023 Board of Directors as well as leadership positions in the Professional Communities. The Society will welcome six members to the Board of Directors […]
Multi-society Guideline on Venous Disease, Varicose Veins Updated
Contact: Beth Bales Senior Communications Manager, SVS (312) 334-2316 ROSEMONT, ILL. (Dec. 1, 2022) – The Society for Vascular Surgery (SVS) has published an update to the SVS/American Venous Forum 2011 clinical practice guideline (CPG) on the care of patients with varicose veins. This guideline update was developed in collaboration […]
Cordio Medical HearO™ Voice Signature Technology Demonstrates Superior Standard of Care for Heart Failure Patients
Community Study successfully predicted heart failure events, increasing opportunities for preventative care NEW YORK, Nov. 29, 2022 /PRNewswire/ — Cordio Medical, a market-leading medical speech processing platform, shared key findings in the HearO™Community Study: Remote Speech Analysis of Hospitalized Patients with Acute Decompensated Heart Failure that assessed remote speech analysis through the Cordio HearO™application. Dr. William Abraham, […]
Evkeeza® (evinacumab-dgnb) sBLA for Children with Ultra-rare Inherited Form of High Cholesterol Accepted for FDA Priority Review
If approved, Evkeeza would be the first and only treatment of its kind to help children as young as 5 years old control dangerously high levels of LDL cholesterol caused by homozygous familial hypercholesterolemia TARRYTOWN, N.Y., Nov. 30, 2022 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has […]
SIMPLEX QUANTUM, Inc. Completes US Patent Registration of Electrocardiogram Biometric Authentication Technology
The University of Aizu collaborated on development of the technology designed to help verify individuals’ identity and protect data integrity TOKYO–(BUSINESS WIRE)–SIMPLEX QUANTUM, Inc. has completed registration in the United States of a patent for a system designed to accurately authenticate an individual’s electrocardiogram (ECG) waveform data. Patent US 11,500,975 B2 […]
Philips Signs Research Agreement to Explore New Magnet Technologies
Collaboration with leading material scientists focuses on the use of high-temperature superconductors to make MR imaging more affordable, accessible and sustainable in the future Operating at higher temperatures and eliminating the use of liquid helium during both production and operation could reduce the size, weight and cost of MRI scanners, […]
GE Healthcare’s AIR Recon DL Technology Recognized by Popular Science Magazine in the ‘Best of What’s New’ Awards
AIR Recon DL is GE Healthcare’s pioneering deep-learning based technology that provides for clinical efficiency by enabling shorter scan times with higher resolution in MRI clinical procedures CHICAGO–(BUSINESS WIRE)–GE Healthcare announced today that it was recognized in the annual ‘Best of What’s New’ awards by Popular Science Magazine. The award highlights GE […]
Broadview Ventures Appoints Michael Mendelsohn, MD to its Strategic Advisory Board
BOSTON – November 30, 2022 – Broadview Ventures, a mission-driven, cardiovascular health-focused investment organization, today announced the appointment of Michael E. Mendelsohn, MD to its Strategic Advisory Board. Dr. Mendelsohn is an internationally recognized cardiovascular physician-scientist, industry research leader and biopharma executive with four decades of broad healthcare and medical experience. Dr. Mendelsohn is […]



